Moderna (MRNA) Other financing activities (2018 - 2019)
Moderna (MRNA) reported Other financing activities of -$3.7 million for Q4 2019, down 137.2% year-over-year from $9.9 million in Q4 2018, and down 200.0% quarter-over-quarter from $3.7 million in Q2 2019.
Moderna (MRNA) Other financing activities (2018 - 2019) Analysis & Trends
Moderna (MRNA) has 2 years of Other financing activities data on file, last reported at -$3.7 million in Q4 2019.
- Other financing activities for Q4 2019 came in at -$3.7 million, down 137.2% year-over-year; the trailing twelve-month figure through Sep 2019 was $13.6 million (changed N/A YoY), and the FY2025 annual result was $22.0 million, changed N/A from the prior year.
- Other financing activities eased to -$3.7 million in Q4 2019 per MRNA's latest filing, from $3.7 million in the prior quarter.
- Over five years, Other financing activities peaked at $9.9 million in Q4 2018 and troughed at -$3.7 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -3.68 Mn |
| Dec 31, 2019 | -3.68 Mn |
| Jun 30, 2019 | 3.68 Mn |
| Jun 30, 2019 | 3.68 Mn |
| Dec 31, 2018 | 9.89 Mn |
| Dec 31, 2018 | 9.89 Mn |
| Jun 30, 2018 | 20,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Mar 31, 2018 | 1.73 Mn |
| Mar 31, 2018 | 1.73 Mn |